Evaluating efficacy of unani formulation in Acne.
Phase 2
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2023/10/058541
- Lead Sponsor
- ational Research Institute of Unani Medicine for Skin Disorders
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants of any gender in the age group between 12 to 30 years.
Participants having any of the following symptoms of Buthur Labaniyya as Comedones, Papules,Pustules ,Nodules, Itching , Erythema.
Participants who are willing to participate and comply with the protocol and to sign IEC approved informed consent / assent form.
Exclusion Criteria
Participants aged <12 years and > 30 years.
Participants with other variants of acne like acne fulminans, acne rosacea, acne necrotica.
Participants suffering from other concomitant diseases like vitiligo, dermatophytosis, psoriasis and eczema.
Pregnant or Nursing Women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25% Reduction in Global Acne Grading System Score from baseline <br/ ><br>Timepoint: 6 Weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Reduction in Cooks Acne Grading Scale , Dermatology Life Quality Index , Visual Analogue Scale Score from baseline <br/ ><br>2. Improvement in symptoms from baseline <br/ ><br> <br/ ><br>Timepoint: 6 Weeks